RS

Ravi Sachdeva

Active Director Director DIN 06921272
DIN 06921272 First appointment Jul 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Ravi Sachdeva

Data last updated:

Ravi Sachdeva is a Director at Anuj Biotech Private Limited (since 2014). The company operates in Pharma. Anuj Biotech Private Limited reported revenue of ₹1.3 Lakh (FY 2023).

DIN 06921272
Primary Designation Director
Industry Pharma
First Appointment 01 Jul 2014
Oldest Company Age 23 yrs
Largest company Anuj Biotech Private Limited · ₹1.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anuj Biotech Private Limited U24231DL2003PTC120947
Director01 Jul 20142003₹1.3 Lakh (FY 2023)Active

Board colleagues of Ravi Sachdeva

Directorship timeline

Open interactive timeline →
Anuj Biotech Private Limited
Premium access

Shareholding and investment profile for Ravi Sachdeva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Sachdeva

Ravi Sachdeva currently holds 1 directorship: Anuj Biotech Private Limited (Director, since 01 Jul 2014, revenue ₹1.3 Lakh (FY 2023)).

Ravi Sachdeva was first appointed on 01 Jul 2014 as Director at Anuj Biotech Private Limited.

The current boards of Ravi Sachdeva's companies include Krishan Chand (Anuj Biotech Private Limited), Satish Kumar (Anuj Biotech Private Limited), Vinod Kumar (Anuj Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available